These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 26427878)
1. Oral fungal immunomodulatory protein-Flammulina velutipes has influence on pulmonary inflammatory process and potential treatment for allergic airway disease: A mouse model. Chu PY; Sun HL; Ko JL; Ku MS; Lin LJ; Lee YT; Liao PF; Pan HH; Lu HL; Lue KH J Microbiol Immunol Infect; 2017 Jun; 50(3):297-306. PubMed ID: 26427878 [TBL] [Abstract][Full Text] [Related]
2. Alleviation of Dermatophagoides microceras-induced allergy by an immunomodulatory protein, FIP-fve, from Flammulina velutipes in mice. Chang YC; Hsiao YM; Hung SC; Chen YW; Ou CC; Chang WT; Lue KH; Ko JL Biosci Biotechnol Biochem; 2015; 79(1):88-96. PubMed ID: 25209380 [TBL] [Abstract][Full Text] [Related]
3. Effect of the fungal immunomodulatory protein FIP-fve on airway inflammation and cytokine production in mouse asthma model. Lee YT; Lee SS; Sun HL; Lu KH; Ku MS; Sheu JN; Ko JL; Lue KH Cytokine; 2013 Jan; 61(1):237-44. PubMed ID: 23107824 [TBL] [Abstract][Full Text] [Related]
4. Fungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokine. Lee YT; Wu CT; Sun HL; Ko JL; Lue KH J Microbiol Immunol Infect; 2018 Oct; 51(5):598-607. PubMed ID: 28709839 [TBL] [Abstract][Full Text] [Related]
5. Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes. Chang YC; Chow YH; Sun HL; Liu YF; Lee YT; Lue KH; Ko JL Antiviral Res; 2014 Oct; 110():124-31. PubMed ID: 25131377 [TBL] [Abstract][Full Text] [Related]
6. Interruption of lung cancer cell migration and proliferation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes. Chang YC; Hsiao YM; Wu MF; Ou CC; Lin YW; Lue KH; Ko JL J Agric Food Chem; 2013 Dec; 61(49):12044-52. PubMed ID: 24274472 [TBL] [Abstract][Full Text] [Related]
7. Effect of the Fungal Immunomodulatory Protein FIP-fve in the Neutrophilic Asthma Animal Model. Pan HH; Ko JL; Wu CT; Sun HL; Quek YW; Ku MS; Lue KH Int Arch Allergy Immunol; 2021; 182(12):1143-1154. PubMed ID: 34649239 [TBL] [Abstract][Full Text] [Related]
8. Systematic Characterization of the Group 2 House Dust Mite Allergen in Hu RH; Wu CT; Wu TS; Yu FY; Ko JL; Lue KH; Liu YF Front Cell Infect Microbiol; 2021; 11():793559. PubMed ID: 35111694 [TBL] [Abstract][Full Text] [Related]
9. Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model. Verheijden KA; Willemsen LE; Braber S; Leusink-Muis T; Delsing DJ; Garssen J; Kraneveld AD; Folkerts G Respir Res; 2015 Feb; 16(1):17. PubMed ID: 25849971 [TBL] [Abstract][Full Text] [Related]
10. A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom, Flammulina velutipes and its complete amino acid sequence. Ko JL; Hsu CI; Lin RH; Kao CL; Lin JY Eur J Biochem; 1995 Mar; 228(2):244-9. PubMed ID: 7705335 [TBL] [Abstract][Full Text] [Related]
11. Effects of Local Nasal Immunotherapy with FIP-fve Peptide and Denatured Tyrophagus putrescentiae for Storage Mite-Induced Airway Inflammation. Yen CY; Yu CH; Tsai JJ; Tseng HK; Liao EC Arch Immunol Ther Exp (Warsz); 2022 Jan; 70(1):6. PubMed ID: 35099617 [TBL] [Abstract][Full Text] [Related]
12. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma. Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909 [TBL] [Abstract][Full Text] [Related]
13. Functional expression of FIP-fve, a fungal immunomodulatory protein from the edible mushroom Flammulina velutipes in Pichia pastoris GS115. Lin JW; Jia J; Shen YH; Zhong M; Chen LJ; Li HG; Ma H; Guo ZF; Qi MF; Liu LX; Li TL J Biotechnol; 2013 Dec; 168(4):527-33. PubMed ID: 24070903 [TBL] [Abstract][Full Text] [Related]
14. Application of thermal stability difference to remove flammutoxin in fungal immunomodulatory protein, FIP-fve, extract from Flammulina velutipes. Tung CH; Lin CC; Wang HJ; Chen SF; Sheu F; Lu TJ J Food Drug Anal; 2018 Jul; 26(3):1005-1014. PubMed ID: 29976393 [TBL] [Abstract][Full Text] [Related]
15. [Inducible and constitutive expression of fip-fve from Flammulina velutipes in Pichia pastoris GS115]. Lin J; Jia J; Zhong M; Chen L; Li H; Guo Z; Qi M; Liu L; Li T Sheng Wu Gong Cheng Xue Bao; 2014 Mar; 30(3):464-71. PubMed ID: 25007582 [TBL] [Abstract][Full Text] [Related]
16. Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model. Yang J; Ramirez Moral I; van 't Veer C; de Vos AF; de Beer R; Roelofs JJTH; Morgan BP; van der Poll T Respir Res; 2019 Jul; 20(1):165. PubMed ID: 31340811 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous prostaglandin E(2) restrains airway mast cell activity in vivo and reduces lung eosinophilia and Th(2) cytokine overproduction in house dust mite-sensitive mice. Herrerias A; Torres R; Serra M; Marco A; Roca-Ferrer J; Picado C; de Mora F Int Arch Allergy Immunol; 2009; 149(4):323-32. PubMed ID: 19295236 [TBL] [Abstract][Full Text] [Related]
18. Oral administration of an Enoki mushroom protein FVE activates innate and adaptive immunity and induces anti-tumor activity against murine hepatocellular carcinoma. Chang HH; Hsieh KY; Yeh CH; Tu YP; Sheu F Int Immunopharmacol; 2010 Feb; 10(2):239-46. PubMed ID: 19909827 [TBL] [Abstract][Full Text] [Related]
19. Targeted reduction of CCR4⁺ cells is sufficient to suppress allergic airway inflammation. Honjo A; Ogawa H; Azuma M; Tezuka T; Sone S; Biragyn A; Nishioka Y Respir Investig; 2013 Dec; 51(4):241-9. PubMed ID: 24238232 [TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and expression of a fungal immunomodulatory protein, FIP-fve, from Flammulina velutipes. Ko JL; Lin SJ; Hsu CI; Kao CL; Lin JY J Formos Med Assoc; 1997 Jul; 96(7):517-24. PubMed ID: 9262056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]